Carver Bancorp to delist from Nasdaq, move to OTCQX market

B. Riley Financial Inc. has received an extension from Nasdaq to complete its overdue quarterly financial reports, allowing the firm to remain listed on the stock exchange. Despite this reprieve, the company's shares fell by 15% during trading in New York.

Creative Realities has made adjustments to its board composition in response to guidance from Nasdaq. This decision reflects the company's commitment to aligning with regulatory expectations and enhancing its governance structure.

The Nasdaq panel has granted B. Riley Financial continued listing status, allowing the company to meet specific filing deadlines. This decision reflects the company's compliance with Nasdaq's requirements, ensuring its shares remain publicly traded. B. Riley Financial's ongoing presence on the exchange is crucial for its operational stability and investor confidence.

Nasdaq participated in the Global Conference, focusing on the integration of Generative AI (Gen AI) to drive growth. The event highlighted Nasdaq's commitment to leveraging advanced technologies to enhance its market position and operational efficiency. This initiative aligns with broader trends in the financial sector, where companies increasingly adopt AI solutions to improve services and competitiveness.

Sinovac is facing potential delisting from the Nasdaq due to delays in filing its annual report. The company has not met the exchange's deadline, raising concerns about its compliance with regulatory requirements. This situation reflects ongoing challenges for Sinovac as it navigates the complexities of maintaining its listing status in a competitive market.

Salarius Pharmaceuticals has confirmed its continued listing on the Nasdaq following a recent merger. The company clarified that it meets all necessary requirements to maintain its status on the exchange. This announcement comes as part of Salarius's ongoing efforts to enhance its market position and investor confidence after the merger.